Parametric Portfolio Associates’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$95K	Sell	37,212 -27,878	-43%	-$68.1K	﹤0.01%	3572
2021 Q4	$191K	Buy	+65,090	New	+$141K	﹤0.01%	3435
2021 Q3	–	Sell	-214,286	Closed	-$872K	–	3670
2021 Q2	$872K	Buy	214,286 +20,281	+10%	+$77.4K	﹤0.01%	2831
2021 Q1	$875K	Buy	194,005 +16,174	+9%	+$87.2K	﹤0.01%	3224
2020 Q4	$875K	Sell	177,831 -36,032	-17%	-$180K	﹤0.01%	3117
2020 Q3	$1.27M	Sell	213,863 -14,609	-6%	-$58.4K	﹤0.01%	2772
2020 Q2	$608K	Buy	228,472 +154,598	+209%	+$538K	﹤0.01%	3175
2020 Q1	$144K	Sell	73,874 -20,094	-21%	-$86.4K	﹤0.01%	3640
2019 Q4	$662K	Buy	93,968 +28,849	+44%	+$238K	﹤0.01%	3259
2019 Q3	$640K	Buy	65,119 +10,346	+19%	+$116K	﹤0.01%	3246
2019 Q2	$627K	Buy	54,773 +1,434	+3%	+$15.1K	﹤0.01%	3272
2019 Q1	$536K	Buy	53,339 +24,577	+85%	+$315K	﹤0.01%	3302
2018 Q4	$489K	Sell	28,762 -1,161	-4%	-$23.3K	﹤0.01%	3320
2018 Q3	$526K	Buy	29,923 +8,223	+38%	+$178K	﹤0.01%	3392
2018 Q2	$412K	Buy	+21,700	New	+$422K	﹤0.01%	3420